arrow
返回
A

A. Malmberg

uppsala university

6H指数
28论文数
1.2K被引数
收录论文 4
发表时间
Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAMx4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumorsI/II期剂量递增/扩展试验,旨在评估DuoBody-EpCAMx4-1BB(BNT314/GEN1059)单药或联合免疫检查点抑制剂在恶性实体瘤患者中的安全性与初步疗效。
err2024-09-01
err0
PREAI
errMelero, I.; Lakhani, N. J.; Powderly, J.; Adjei, A. A.; Lopez, J. S.; Paz-Ares, L. G.; Moreno Candilejo, I.; Thistlethwaite, F.; Rohrberg, K. S.; Jerusalem, G.; Malmberg, A.; Ioan-Facsinay, A.; Upadhyay, P. J.; Tan, B.; Bartz, R.; Gaziel, T. B. B.; Forssmann, U.; Celik, I.; Gann, C.; De Mattos-Arruda, L.
err分享
err收藏
Myopia, knowledge development and cluster evolution
err2007-06-13
err344
PREAI
errMaskell, Peter; Malmberg, Anders
err分享
err收藏